Cancer

Building a Better FIT Test for Colon Cancer Screening

12 days ago   |   By Medscape

An antibody-based multitarget FIT for colorectal cancer screening is more accurate in detecting advanced neoplasia compared with the standard FIT test, report Dutch researchers.
Reuters Health Information
Read more ...

 

Q&A: Multitarget FIT bests regular FIT in adenoma detection

Q&A: Multitarget FIT bests regular FIT in adenoma detection

12 days ago   |   By Healio

Multitarget fecal immunochemical testing yielded better diagnostic accuracy in the detection of advanced adenomas compared with basic FIT, according to research published in Annals of Internal Medicine.
“Early detection is the most realistic approach for reducing death from colorectal cancer and programmatic stool-based screening, using FIT, has been very successful,” Meike de Wit, PhD, Netherlands Cancer Institute, told Healio. “However, the sensitivity of FIT for relevant precursor lesions, advanced adenomas, is not that high and improving that sensitivity for advanced
Read more ...

 


Search by Tags

   Cancer      Hematology-Oncology      News  


Cholangiopathy after severe COVID-19 may lead to liver injury, failure

Cholangiopathy after severe COVID-19 may lead to liver injury, failure

For patients with severe COVID-19, cholangiopathy was a late complication with potential for progressive biliary injury or liver failure, according to a study published in the... Read more ...

Mississippi woman pleads others to get vaccinated as her husband is hospitalized

Mississippi woman pleads others to get vaccinated as her husband is hospitalized

William Thomas Ball, 51, has been hospitalized with COVID-19 in Jackson, Mississippi after refusing to get vaccinated. Now his wife, Alicia, is asking for others in her... Read more ...

Covid England: Cases are now falling in ALL age groups, official data reveals

Covid England: Cases are now falling in ALL age groups, official data reveals

EXCLUSIVE: Covid cases are falling in all age groups, and dropping fastest among adults in their twenties according to data from the Department of Health. Read more ...

Lumbar artificial disc yielded positive 7-year outcomes for degenerative...

Lumbar artificial disc yielded positive 7-year outcomes for degenerative disc disease

For total disc replacement in patients with degenerative disc disease, an artificial disc is a safe option that improves pain relief, function, range of motion and decreases in... Read more ...

FDA clamps down on imported shark fins, cantaloupes, mushrooms and more

FDA clamps down on imported shark fins, cantaloupes, mushrooms and more

The Food and Drug Administration uses import alerts to enforce U.S. food safety regulations for food from foreign countries. The agency updates and modifies the alerts as... Read more ...

FDA TechTalk podcast episode to focus on whole genome sequencing

FDA TechTalk podcast episode to focus on whole genome sequencing

Nowadays, it seems rare to find someone or some entity without a podcast, and the Food and Drug Administration is no exception. The TechTalk podcast is hosted by the FDA and... Read more ...

COVID Breakthrough Cases Ran the Gamut in Healthcare Workers

COVID Breakthrough Cases Ran the Gamut in Healthcare Workers

Breakthrough COVID-19 cases in fully vaccinated healthcare workers were rare, and generally were associated with the individual's immune response to the vaccine in the early... Read more ...

Some IBD Treatments in Pregnancy Had No Effect on Kids' Infection Risk

Some IBD Treatments in Pregnancy Had No Effect on Kids' Infection Risk

Exposure to immunosuppressive monotherapies in utero did not increase serious infection risks in young children born to mothers with inflammatory bowel disease , but the same... Read more ...

FDA issues complete response letter for retifanlimab for anal cancer

FDA issues complete response letter for retifanlimab for anal cancer

The FDA issued a complete response letter to Incyte indicating it cannot approve the company's biologics license application that seeks approval of retifanlimab for certain... Read more ...

Bristol Myers Squibb withdraws liver cancer indication for nivolumab

Bristol Myers Squibb withdraws liver cancer indication for nivolumab

Bristol Myers Squibb in consultation with the FDA voluntarily withdrew the indication for nivolumab as monotherapy for patients with hepatocellular carcinoma previously treated... Read more ...